These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32579280)

  • 21. [A place for SSRIs in the treatment of severely depressed children and adolescents].
    Roobol TH; Buitelaar JK
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1710-2. PubMed ID: 18727599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH; Entsuah R; Hackett D
    Int Clin Psychopharmacol; 2002 Nov; 17(6):273-80. PubMed ID: 12409680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R; Chen J; Entsuah AR; Schatzberg AF
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment-resistant depressed youth show a higher response rate if treatment ends during summer school break.
    Shamseddeen W; Clarke G; Wagner KD; Ryan ND; Birmaher B; Emslie G; Asarnow JR; Porta G; Mayes T; Keller MB; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1140-8. PubMed ID: 22024002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluoxetine: an update of its use in major depressive disorder in adults].
    Gourion D; Perrin E; Quintin P
    Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study.
    Zhou J; Wang X; Feng L; Xiao L; Yang R; Zhu X; Shi H; Hu Y; Chen R; Boyce P; Wang G
    BMC Psychiatry; 2021 May; 21(1):260. PubMed ID: 34011310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
    Mansoor B; Rengasamy M; Hilton R; Porta G; He J; Spirito A; Emslie GJ; Mayes TL; Clarke G; Wagner KD; Shamseddeen W; Birmaher B; Ryan N; Brent D
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):458-67. PubMed ID: 24024532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
    Sir A; D'Souza RF; Uguz S; George T; Vahip S; Hopwood M; Martin AJ; Lam W; Burt T
    J Clin Psychiatry; 2005 Oct; 66(10):1312-20. PubMed ID: 16259546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
    Bondar J; Caye A; Chekroud AM; Kieling C
    Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Out of the black box: treatment of resistant depression in adolescents and the antidepressant controversy.
    Wagner KD; Asarnow JR; Vitiello B; Clarke G; Keller M; Emslie GJ; Ryan N; Porta G; Iyengar S; Ritz L; Zelanzny J; Onorato M; Brent D
    J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):5-10. PubMed ID: 22251022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 35. Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.
    Shelton C; Entsuah R; Padmanabhan SK; Vinall PE
    Int Clin Psychopharmacol; 2005 Jul; 20(4):233-8. PubMed ID: 15933485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    Lin CH; Lin KS; Lin CY; Chen MC; Lane HY
    J Clin Psychiatry; 2008 Jan; 69(1):54-9. PubMed ID: 18312038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM; Entsuah R; Rudolph RL
    Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA; Hanwella R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
    de Carvalho GA; Bahls SC; Boeving A; Graf H
    Thyroid; 2009 Jul; 19(7):691-7. PubMed ID: 19583486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings.
    Lynch FL; Dickerson JF; Clarke G; Vitiello B; Porta G; Wagner KD; Emslie G; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes T; DeBar L; McCracken JT; Strober M; Suddath RL; Spirito A; Onorato M; Zelazny J; Iyengar S; Brent D
    Arch Gen Psychiatry; 2011 Mar; 68(3):253-62. PubMed ID: 21383263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.